Niraparib maintenance therapy using an individualised starting dose in patients with platinum-sensitive recurrent ovarian cancer (NORA): final overall survival analysis of a phase 3 randomised, placebo-controlled trial
在铂敏感复发性卵巢癌患者中采用个体化起始剂量进行尼拉帕尼维持治疗（NORA）：一项3期随机、安慰剂对照试验的最终总生存期分析
期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2024.102629
Wu, Xiaohua; Zhu, Jianqing; Yin, Rutie; Yang, Jiaxin; Liu, Jihong; Wang, Jing; Wu, Lingying; Liu, Ziling; Gao, Yunong; Wang, Danbo; Lou, Ge; Yang, Hongying; Zhou, Qi; Kong, Beihua; Huang, Yi; Chen, Lipai; Li, Guiling; An, Ruifang; Wang, Ke; Zhang, Yu; Yan, Xiaojian; Lu, Xin; Lu, Weiguo; Hao, Min; Wang, Li; Cui, Heng; Chen, Qionghua; Abulizi, Guzhalinuer; Huang, Xianghua; Tian, Xiaofei; Wen, Hao; Huang, Zhao; Dong, Juan; Zhang, Charlie; Hou, Jianmei; Mirza, Mansoor R
